Baxter International Inc BAX

Morningstar Rating
$22.62 +0.16 (0.71%)
View Full Chart

Company Report

Price vs Fair Value

BAX is trading at a LOCK|&p#xV premium.
Price
$22.62
Fair Value
?^V
Uncertainty
LOCK|hP
1-Star Price
#B
5-Star Price
@@@
Economic Moat
LOCK|k&>%<
Capital Allocation
LOCK|<s

Bulls Say, Bears Say

Bulls

In the long run, Baxter should continue to grow at a decent clip, primarily around evolutionary innovation in all of the major business lines and moderate pricing or mix improvements.

Bears

Although Baxter's products are essential for medical care and patient health, GPO contract negotiations can limit pricing power and flexibility.

News

Articles & Videos

Trading Information

Previous Close Price
$22.46
Day Range
$22.3522.72
52-Week Range
$15.7329.52
Bid/Ask
$22.50 / $22.92
Shares Outstanding
516.47M
Market Cap
$11.68B
Volume/Avg
3M / 7M

Key Statistics

Price/Earnings (Normalized)
11.04
Price/Sales
1.04
Dividend Yield (Trailing)
0.88%
Dividend Yield (Forward)
0.88%
Total Yield
0.88%

Company Profile

Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Small Value
Total Number of Employees
37,500

Competitors

Valuation

Metric
BAX
BDX
ICUI
Price/Earnings (Normalized)
11.0411.6219.40
Price/Book Value
1.951.781.84
Price/Sales
1.042.171.81
Price/Cash Flow
10.4111.2612.58
Price/Earnings
BAX
BDX
ICUI

Financial Strength

Metric
BAX
BDX
ICUI
Quick Ratio
1.010.360.99
Current Ratio
1.850.942.34
Interest Coverage
−0.933.531.03
Quick Ratio
BAX
BDX
ICUI

Profitability

Metric
BAX
BDX
ICUI
Return on Assets (Normalized)
4.98%4.29%2.75%
Return on Equity (Normalized)
15.23%9.24%5.37%
Return on Invested Capital (Normalized)
7.36%6.41%4.97%
Return on Assets
BAX
BDX
ICUI

Medical Instruments & Supplies Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Intuitive Surgical Inc
ISRG
LOCK|z&XvT^^LOCK|x!w$144B
Becton Dickinson & Co
BDX
LOCK|MLLOCK|BCJMt$42B
Medline Inc Ordinary Shares - Class A
MDLN
LOCK|l$>&S#LOCK|h%H$$35B
Alcon Inc
ALC
LOCK|<rGjn?LOCK|!bth$33B
ResMed Inc
RMD
LOCK|Q#<WY@?XLOCK|gPF$?$30B
West Pharmaceutical Services Inc
WST
LOCK|^zsKkHDGLOCK|fz$25B
The Cooper Companies Inc
COO
LOCK|!gz!&m#LOCK|k$Xy$14B
Solventum Corp
SOLV
LOCK|bkl$j@LOCK|<m%$13B
Align Technology Inc
ALGN
LOCK|hMjS%&TLOCK|psN#$13B

Sponsor Center